Chenodeoxycholic Acid
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB06777 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 55 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | homozygous familial hypercholesterolemia | KG + DL |
| 2 | brain small vessel disease 1 with or without ocular anomalies | KG + DL |
| 3 | autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome | KG + DL |
| 4 | obsolete familial combined hyperlipidemia | KG + DL |
| 5 | obsolete hyperuricemia (disease) | KG + DL |
| 6 | hypouricemia, renal | KG + DL |
| 7 | diabetic nephropathy | KG + DL |
| 8 | hypoxanthine guanine phosphoribosyltransferase partial deficiency | KG + DL |
| 9 | familial isolated hypoparathyroidism due to impaired PTH secretion | KG + DL |
| 10 | Lesch-Nyhan syndrome | KG + DL |
| 11 | biotin metabolic disease | KG + DL |
| 12 | renal tubular acidosis | KG + DL |
| 13 | acromesomelic dysplasia, Campailla Martinelli type | KG + DL |
| 14 | Dahlberg-Borer-Newcomer syndrome | KG + DL |
| 15 | vitamin deficiency disorder | KG + DL |
| 16 | congestive heart failure | KG + DL |
| 17 | craniofacial conodysplasia | KG + DL |
| 18 | pseudo-von Willebrand disease | KG + DL |
| 19 | primary release disorder of platelets | KG + DL |
| 20 | inborn error of biotin metabolism | KG + DL |
| 21 | acute pulmonary heart disease | KG + DL |
| 22 | bone Paget disease | KG + DL |
| 23 | inborn disorder of pyridoxine metabolism | KG + DL |
| 24 | hypoparathyroidism | KG + DL |
| 25 | cerebral folate deficiency | KG + DL |
| 26 | constitutional megaloblastic anemia due to folate metabolism disorder | KG + DL |
| 27 | Glanzmann thrombasthenia | KG + DL |
| 28 | sitosterolemia | KG + DL |
| 29 | hypercholesterolemia, autosomal dominant | KG + DL |
| 30 | HIV infectious disease | KG + DL |
| 31 | cholestasis, intrahepatic, of pregnancy | KG + DL |
| 32 | neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter | KG + DL |
| 33 | hypolipoproteinemia (disease) | KG + DL |
| 34 | oral candidiasis | KG + DL |
| 35 | osteoradionecrosis of the mandible | KG + DL |
| 36 | commissural lip fistula | KG + DL |
| 37 | familial hypercholesterolemia | KG + DL |
| 38 | oral leukoedema | KG + DL |
| 39 | burning mouth syndrome | KG + DL |
| 40 | hypoglycemia | KG + DL |
| 41 | chronic kidney disease | KG + DL |
| 42 | Ledderhose disease | KG + DL |
| 43 | familial isolated deficiency of vitamin E | KG + DL |
| 44 | hypoalphalipoproteinemia | KG + DL |
| 45 | infantile digital fibromatosis | KG + DL |
| 46 | feline acquired immunodeficiency syndrome | KG + DL |
| 47 | simian immunodeficiency virus infection | KG + DL |
| 48 | disorder of vitamin and non-protein cofactor absorption and transport | KG + DL |
| 49 | palmar fibromatosis | KG + DL |
| 50 | disorder of phenylalanine metabolism | KG + DL |
(Showing top 50 of 55 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.